111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung

Journal of Nuclear Medicine

Volumn 42, Issue 9, 2001, Pages 1309-1315

  Traub, T ^a   Petkov, V ^a   Ofluoglu, S ^a   Pangerl, T ^a   Raderer, M ^a   Fueger, B J ^a   Schima, W ^a   Kurtaran, A ^a   Dudczak, R ^a   Virgolini, I ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Lanreotide; Lung cancer; Receptor imaging; Somatostatin

Indexed keywords

INDIUM 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID ANGIOPEPTIN IN 111; INDIUM 111; RADIOISOTOPE; UNCLASSIFIED DRUG; CYCLOPEPTIDE; DIAGNOSTIC AGENT; DOTALAN; DRUG DERIVATIVE; INDIUM; RADIOPHARMACEUTICAL AGENT; SINGLE HETEROCYCLIC RINGS; SOMATOSTATIN;

ADULT; AGED; ANGIOSARCOMA; ARTICLE; BINDING SITE; BONE METASTASIS; CARCINOID; CLINICAL ARTICLE; HUMAN; IN VITRO STUDY; LIGAND BINDING; LUNG CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; WHOLE BODY SCINTISCANNING; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; LUNG TUMOR; METASTASIS; RADIOMETRY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; HETEROCYCLIC COMPOUNDS, 1-RING; INDIUM RADIOISOTOPES; LUNG NEOPLASMS; NEOPLASM METASTASIS; PEPTIDES, CYCLIC; RADIOMETRY; RADIOPHARMACEUTICALS; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034741787     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Transbronchial needle aspiration in routine fiberoptic bronchoscopy
2. Percutaneous thin needle biopsy of malignant and nonmalignant thoracic lesions
3. CT-evaluation of enhancement with iodinated contrast material
4. Prospective investigation of positron emission tomography in lung nodules
5. Cancer of the lung
6. Somatostatin receptor scintigraphy with In-111-DTPA-D-Phel and 1-131-Tyr-3-octreotide: The Rotterdam experience with more than 1000 patients
7. Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer
8. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules
9. Cloning and functional characteristics of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney
10. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylal cyclase
11. Cloning, functional expression and pharmacological characterization of a fourth (hsstr4) and a fifth (hsstr5) human somatostatin receptor subtype
12. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylate cyclase
13. Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20
14. Molecular biology of somatostatin receptors
15. A human somatostatin receptor (SSTR3), located on a chromosome 22, displays preferential affinity for somatostatin-14 like peptides
16. Cloning and characterization of a fourth human somatostatin receptor
17. Somatostatin receptor subtype expression in human tissues: A prediction for diagnosis and treatment of cancer?
18. Indium-111-DOTA-lanreotide: Biodistribution, safety and tumor dose in patients evaluated by somatostatin receptor-mediated radiotherapy
19. DOTA-lanreotide: A novel somatostatin analog for tumor diagnosis and therapy
20. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine
21. Effective dose from radiopharmaceuticals
22. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
23. Somatostatin receptor subtype specificity and in vitro binding of a novel tumor tracer, Tc-99m-P829
24. Somatostatin receptors in human neuroendocrine tumors
25. The attraction of proteins for small molecules and ions
26. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors
27. Vasoactive intestinal peptide (VIP) receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors
28. 1-octreotide in 194 carcinoid patients: Vienna University experience, 1993 to 1998
29. Somatostatin receptor imaging in the localization of endocrine tumors
30. Prospective investigation of positron emission tomography in lung nodules
31. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum
32. Somatostatin receptors are present in small-cell but not in non-small primary lung carcinomas: Relationship to EGF-receptors
33. Transcription of somatostatin receptor subtype 1 and 2 genes in lung cancer
34. Somatostatin receptor expression in lung cancer
35. Distinct subjects of somatostatin receptors on cultured human lymphocytes
36. High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interaction?
37. Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma